Phenotypic characterization of coagulase negative staphylococci from various clinical isolates

Mamta Gour^1*, Kalpana Date², V. R. Thombare³, K. K. Gour⁴

¹Assistant Professor, ⁴Associate Professor, Department of Anatomy, Department of Microbiology, L.N.M.C. Bhopal, Madhya Pradesh, INDIA.

²Associate Professor, ³Professor and HOD, Department of Microbiology, N.K.P. S.I.M.S., Nagpur, Maharashtra, INDIA.

Email: mamtakgour@gmail.com, drkkgour@gmail.com

REFERENCES

1. Badwi JA, Memon AH, Soomro AA. Coagulase Negative Staphylococci (CONS) is the contaminant in the clinical specimen. Med Channel 2012; 19:23-7.
2. Makki AR, Sharma S, Duggirala A, Prashanth K, Garg P, Das T. Phenotypic and Genotypic Characterization of Coagulase Negative Staphylococci (CoNS) Other than Staphylococcus epidermidis Isolated from Ocular Infections. Invest Ophthalmol and VisSci 2011; 52:9018-22.
3. Alcaraz LE, Satoress SE, Lucero RM, Puig de Centorbi ON. Species identification, slime production and oxacillin susceptibility in coagulase–negative staphylococci isolated from nosocomial specimens. Braz J Microbiol; 2003, 34; 45-51
4. Singh S, Banerjee G, Agarwal SK, Kumar M, Singh RK. Simple method for speciation of clinically significant Coagulase Negative Staphylococci and its antibiotic sensitivity/resistant pattern in NICU of tertiary care centre. Biomed Res 2008; 19:97-101.
5. Koneman EW, AllenSD, Janda WM, Schreckenberger PC, Winn WC. The Gram Positive Cocci: Part 1: Staphylococci and related organisms. In: Colour atlas and textbook of Diagnostic Microbiology. 6^th edition. Lippincott, Philadelphia, New York, 1997: 539— 576.
6. Miles RS, Amyes SG.Laboratory control of antimicrobial therapy. In:Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and Mc Cartney practical Medical Microbiology. 14th ed. New York:Churchill Livingston;1996. p. 151-78.
7. Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, Woods GL. Gram positive cocci: Staphylococci and related gram positive cocci. In Koneman’s colour atlas and textbook of diagnostic microbiology. 6^th ed, Lippincott Williams and Wilkins, 2006; p 624-73.
8. Huang SY, Tang RB, Chen SJ, Chung RL. Coagulase negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol. Infect, 2003; 36: 51-55.
9. Ieven M, Verhoeven J, Pattyn SR, Goossens H. Rapid and Economical Method for Species Identification of Clinically Significant Coagulase-Negative Staphylococci. J Clin Microbiol 1995;33:1060-3
10. Nord CA,S Holta-Oie, Characterisation of coagulase-negative staphylococcal species from human infections;Zenalbi,Bacteriol,Parisit,Enkd,indektionskz,Hyg.Abt;I, suppl.5;105-111
11. Mohan U, Jindal N, Aggarwal P. Species distribution and antibiotic sensitivity pattern of coagulase negative staphylococci isolated from various clinical specimens. Indian J Med Microbiol 2002;20:45-6
12. Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, Woods GL. Gram positive cocci: Staphylococci and related gram positive cocci. In Koneman’s colour atlas and textbook of diagnostic microbiology. 6^th ed, Lippincott Williams and Wilkins, 2006; p 624-73
13. Sewell CM. Coagulase-Negative Staphylococci and the Clinical Microbiology Laboratory, Eur. J. Clin. Microbiol, 1984; 3: 94-95.
14. Kleeman KT, Bannerman TL, Kloos WE. Species distribution of coagulase negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol, 1993; 31: 1318-21.
15. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, et al. Survey of Infections Due to StaphylococcusSpecies: Frequency of Occurrenceand Antimicrobial Susceptibility of IsolatesCollected in the United States, Canada, LatinAmerica, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program,1997-1999. Clin Infect Dis 2001;32(suppl2):S114-32
16. Huang SY, Tang RB, Chen SJ, Chung RL. Coagulase negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol. Infect, 2003; 36: 51-55.